Adma Biologics (ADMA) Goodwill & Intangibles (2017 - 2025)

Adma Biologics has reported Goodwill & Intangibles for 9 years, with the latest figure at $4.1 million in Q4 2025.

• For the quarter ending Q4 2025, Goodwill & Intangibles rose 4.34% year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2025 stood at $4.1 million (up 4.34% YoY), and the FY2025 full-year result was $4.1 million, up 4.34% from the prior year.
• Goodwill & Intangibles for Q4 2025 stood at $4.1 million, up from $4.0 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $9.6 million in Q2 2021, with the low at $3.8 million in Q1 2024.
• Historically, Goodwill & Intangibles has averaged $5.4 million across 5 years, with a median of $4.5 million in 2022.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles jumped 127.04% — and 2025, when it sank 55.79%.
• Adma Biologics' Goodwill & Intangibles stood at $5.3 million in 2021, then retreated by 13.6% to $4.5 million in 2022, then dropped by 11.97% to $4.0 million in 2023, then decreased by 0.98% to $4.0 million in 2024, then rose by 4.34% to $4.1 million in 2025.
• The last three Goodwill & Intangibles figures came in at $4.1 million (Q4 2025), $4.0 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.